A Dendritic Cell Subset Targeting Approach for Generating Humoral Immunity

Abstract

Potent vaccination might be achieved by using monoclonal antibodies as magic bullets to target vaccines to special cells in the body. We show that targeting these special cells by using monoclonal antibodies that recognise Clec9A is effective, perhaps because it brings several different immune cells together so that they orchestrate very efficient immune responses. This application investigates how targeting Clec9A allows strong vaccination so that we can apply this to new generation vaccines.

Related publications (1)

DEC-205 is a cell surface receptor for CpG oligonucleotides

MH Lahoud, F Ahmet, JG Zhang, S Meuter, AN Policheni, S Kitsoulis, CN Lee, M O'Keeffe, LC Sullivan, AG Brooks, R Berry, J Rossjohn, JD Mintern, J Vega-Ramos, JA Villadangos, NA Nicola, MC Nussenzweig, KJ Stacey, K Shortman, WR Heath

2012-10-02

Synthetic CpG oligonucleotides (ODN) have potent immunostimulatory properties exploited in clinical vaccine trials. How CpG ODN ar..